Pharmacologic reversion of Merkel cell carcinoma via CBP/p300 inhibition

Journal:

Proceedings of the National Academy of Sciences of the United States of America

Published:

2025-12-24

DOI:

10.1073/pnas.2516667122

Affiliations:

7

Authors:

10

Go to article

Institutions	Authors	Share
UPMC Hillman Cancer Center (UPCI), United States of America (USA)	2.500000	0.25
University of Pittsburgh (Pitt), United States of America (USA)	2.500000	0.25
German Consortium of Translational Cancer Research (DKTK), Germany	2.333333	0.23
University of Duisburg-Essen (UDE), Germany	1.666667	0.17
University of Tours (UFR), France	1.000000	0.10

Interested in Oncology and Carcinogenesis?